T2 BIOSYSTEMS IS TRANSFORMING DIAGNOSTICS, PATIENT CARE AND ECONOMICS.
Proven technology that delivers tangible benefits for patients, practitioners and healthcare institutions.
WEBINAR: T2Candida Clinical Impact
Learn from renowned clinical expert, George Alangaden MD, FACP, FIDSA discuss The Clinical Impact and Implementation of T2MR and the T2Candida Panel (PACE CE | Florida CE)
Save Lives and Money
Reduce 60% of Candida deaths and save $30K per patient.
How to detect Candida pathogens commonly associated with sepsis - independent of blood culture.
T2Candida demonstrates 91.1% sensitivity and 99.4% specificity. Learn more.
News & Events
February 10, 2017
Tom Lowery is Featured in the Article T2MR Technology and its Ability to Offer new Insights into Hemostasis - Genomeweb
November 12, 2016
T2 Reports Annual Cost Saving of Up to $3M for Hospital Using Rapid Sepsis MDx - Genomeweb
November 03, 2016
Data Demonstrates Clinical and Economic Benefits of T2 Magnetic Resonance (T2MR®) Technology in Clinical Settings